NDRA
ENDRA Life Sciences Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$6.05
+6.51%Leverage
- Debt / equity
- 0.07x
- Net debt / equity
- -0.21x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.06x
- Net debt / EBITDA
- 0.18x
Liquidity & coverage
- Current ratio
- 7.10x
- Quick ratio
- 7.10x
- Cash ratio
- 2.21x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $4.8M
Cash & dividend
- FCF / debt
- -18.27x
- Cash flow / debt
- -11.24x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026